5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.07▼ | 1.07▼ | 1.07▼ | 1.07▼ | 1.06▼ |
MA10 | 1.06▼ | 1.06▼ | 1.06▼ | 1.06▼ | 1.15▼ |
MA20 | 1.06▼ | 1.07▼ | 1.07▼ | 1.07▼ | 1.51▼ |
MA50 | 1.20▼ | 1.23▼ | 1.24▼ | 1.20▼ | 1.88▼ |
MA100 | 1.55▼ | 1.57▼ | 1.58▼ | 1.53▼ | 3.18▼ |
MA200 | 1.57▼ | 1.58▼ | 1.63▼ | 1.67▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.016▲ | 0.016▲ | 0.017▲ | 0.014▲ | -0.025▼ |
RSI | 41.315▼ | 40.490▼ | 40.413▼ | 42.488▼ | 35.327▼ |
STOCH | 78.333 | 78.333 | 78.333 | 56.519 | 12.017▼ |
WILL %R | -46.154 | -46.154 | -46.154 | -48.652 | -90.400▼ |
CCI | 14.894 | 0.696 | 0.696 | -0.230 | -72.769 |
Thursday, May 16, 2024 01:15 PM
The biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by Jiangsu Hengrui Pharmaceuticals, two of which are in clinical testing.
|
Thursday, May 16, 2024 09:45 AM
Hagens Berman is urging investors who suffered substantial losses in Zoetis Inc. (NYSE: ZTS) to promptly report their losses here. Additionally, individuals ...
|
Thursday, May 16, 2024 05:12 AM
Operator: Thank you for standing by and welcome to the Allurion First Quarter Earnings Call. All lines have been placed on mute to prevent any background noise.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 1.08 | 1.08 | 1.05 | 1.05 | 13,135 |
15/05/24 | 1.08 | 1.12 | 1.0101 | 1.085 | 24,356 |
14/05/24 | 1.05 | 1.14 | 1.05 | 1.07 | 16,682 |
13/05/24 | 1.03 | 1.09 | 1.03 | 1.09 | 1,520 |
10/05/24 | 1.1637 | 1.1637 | 1.0601 | 1.0601 | 3,078 |
09/05/24 | 1.10 | 1.1242 | 1.0621 | 1.105 | 6,102 |
08/05/24 | 1.06 | 1.1169 | 1.02 | 1.1169 | 2,438 |
07/05/24 | 1.0597 | 1.07 | 1.04 | 1.06 | 19,854 |
06/05/24 | 1.02 | 1.06 | 1.02 | 1.02 | 2,482 |
03/05/24 | 1.02 | 1.06 | 0.98 | 0.99 | 24,369 |
|
|
||||
|
|
||||
|
|